Healthcare AI agents must demonstrate safe, authorized, and controlled use of medical tools, APIs, and healthcare systems to prevent unauthorized access, cascading failures, and inappropriate tool selection while maintaining clinical effectiveness and patient safety. This addresses the fundamental difference between traditional AI/ML medical devices and autonomous agents: the ability to dynamically access and control multiple healthcare tools and systems.
Establish comprehensive authorization frameworks for agent tool access with least-privilege principles and clinical appropriateness validation.
| # | Description | Level | Role |
|---|---|---|---|
| 8.1.1 | Verify that healthcare AI agents implement role-based tool access controls limiting agent tool usage to clinically appropriate and pre-authorized medical devices, APIs, and healthcare systems based on agent function and clinical context. | 1 | H/D |
| 8.1.2 | Verify that tool authorization includes real-time validation ensuring agents can only access tools within their regulatory classification scope and clinical competency boundaries. | 1 | H/V |
| 8.1.3 | Verify that agent tool access requires explicit healthcare organization approval with documented clinical rationale and risk assessment for each tool integration. | 1 | H/C |
| 8.1.4 | Verify that tool access controls include time-based restrictions, session limits, and automatic timeout mechanisms preventing unlimited or inappropriate tool usage. | 2 | D/H |
| 8.1.5 | Verify that authorization systems maintain comprehensive audit trails of tool access requests, approvals, denials, and usage patterns for regulatory compliance and security monitoring. | 2 | H/V |
| 8.1.6 | Verify that advanced authorization includes dynamic risk assessment adjusting tool access permissions based on agent performance, clinical context, and real-time risk factors. | 3 | H/D |
Ensure agents select and use appropriate tools for clinical contexts while preventing tool misuse and inappropriate medical device interaction.
| # | Description | Level | Role |
|---|---|---|---|
| 8.2.1 | Verify that healthcare AI agents implement clinical decision logic ensuring tool selection aligns with patient condition, clinical protocols, and evidence-based medicine principles. | 1 | D/C |
| 8.2.2 | Verify that tool selection includes safety validation preventing agents from using tools outside their intended medical purpose, patient population, or clinical indication. | 1 | D/C |
| 8.2.3 | Verify that agents maintain tool compatibility validation ensuring selected tools are appropriate for patient characteristics, clinical setting, and healthcare workflow requirements. | 2 | D/C |
| 8.2.4 | Verify that tool selection logic includes contraindication checking preventing agents from using tools that may harm patients based on medical history, current medications, or clinical condition. | 2 | D/C |
| 8.2.5 | Verify that inappropriate tool usage detection includes automated alerts and human escalation when agents attempt to use tools outside clinical guidelines or safety parameters. | 2 | D/H |
| 8.2.6 | Verify that advanced tool selection includes machine learning-based appropriateness validation continuously improving tool selection accuracy based on clinical outcomes and expert feedback. | 3 | D/C |
Ensure secure and compliant integration with FDA-regulated medical devices and healthcare systems.
| # | Description | Level | Role |
|---|---|---|---|
| 8.3.1 | Verify that AI agent integration with FDA-regulated medical devices maintains device classification integrity and does not alter the original device's intended use or risk classification. | 1 | V |
| 8.3.2 | Verify that medical device integration includes validation that agent use does not interfere with device safety functions, alarms, or clinical performance characteristics. | 1 | D/V |
| 8.3.3 | Verify that agent-device integration follows FDA interoperability guidance and maintains medical device cybersecurity requirements including authentication, encryption, and access controls. | 2 | D/V |
| 8.3.4 | Verify that integration with life-critical medical devices (ventilators, infusion pumps, cardiac monitors) includes enhanced safety validation and mandatory human oversight for agent-initiated actions. | 2 | H/C |
| 8.3.5 | Verify that medical device integration includes fail-safe mechanisms ensuring device continues to operate safely if agent communication fails or agent performs unexpectedly. | 2 | D/H |
| 8.3.6 | Verify that advanced integration includes predictive maintenance and performance optimization for agent-device interactions while maintaining regulatory compliance and patient safety. | 3 | D/V |
Implement secure API usage and healthcare system integration with comprehensive security and privacy protection.
| # | Description | Level | Role |
|---|---|---|---|
| 8.4.1 | Verify that healthcare AI agents implement secure API authentication and authorization using healthcare-standard security protocols (OAuth 2.0, FHIR security) for all external system access. | 1 | D/H |
| 8.4.2 | Verify that API usage includes rate limiting, request validation, and error handling preventing agent overload of healthcare systems and maintaining system availability for other users. | 1 | D/H |
| 8.4.3 | Verify that healthcare system access includes comprehensive logging and monitoring of all API calls, data requests, and system interactions for security analysis and regulatory compliance. | 2 | D/V |
| 8.4.4 | Verify that API security includes input validation and sanitization preventing injection attacks, malicious data submission, and security vulnerabilities in connected healthcare systems. | 2 | D/V |
| 8.4.5 | Verify that healthcare system integration includes data minimization ensuring agents only access necessary patient information and healthcare data required for specific clinical functions. | 2 | D/H |
| 8.4.6 | Verify that advanced API security includes behavioral analysis detecting anomalous agent API usage patterns and potential security threats or misuse scenarios. | 3 | D/V |
Prevent agent tool use from causing cascading failures across connected healthcare systems and medical devices.
| # | Description | Level | Role |
|---|---|---|---|
| 8.5.1 | Verify that healthcare AI agents implement circuit breaker patterns automatically limiting or stopping tool usage when failures, errors, or performance degradation are detected. | 2 | D/H |
| 8.5.2 | Verify that cascading failure prevention includes isolation mechanisms preventing agent-caused problems from spreading across connected healthcare systems and medical devices. | 2 | D/H |
| 8.5.3 | Verify that system resilience includes redundancy and failover capabilities ensuring clinical care continuity when agent tool usage fails or performs unexpectedly. | 2 | H/D |
| 8.5.4 | Verify that failure prevention includes dependency mapping and impact analysis identifying potential failure propagation paths and implementing appropriate safeguards. | 3 | D/V |
| 8.5.5 | Verify that advanced resilience includes predictive failure analysis identifying potential cascading failure scenarios before they occur and implementing proactive mitigation strategies. | 3 | D/V |
Monitor agent tool usage patterns and optimize performance while maintaining clinical effectiveness and safety.
| # | Description | Level | Role |
|---|---|---|---|
| 8.6.1 | Verify that healthcare AI agents implement comprehensive monitoring of tool usage patterns, performance metrics, and clinical outcomes associated with different tool selections. | 2 | H/D |
| 8.6.2 | Verify that tool performance monitoring includes efficiency analysis identifying optimal tool usage patterns and reducing unnecessary healthcare system resource consumption. | 2 | H/D |
| 8.6.3 | Verify that performance optimization includes clinical outcome correlation ensuring tool usage improvements maintain or enhance patient care quality and safety. | 2 | H/C |
| 8.6.4 | Verify that monitoring systems provide healthcare administrators and clinical teams with actionable insights about agent tool usage effectiveness and resource utilization. | 3 | H |
| 8.6.5 | Verify that advanced optimization includes machine learning-based tool usage refinement continuously improving agent efficiency while maintaining clinical appropriateness and safety. | 3 | D/C |
Ensure tool-enabled AI agents meet FDA medical device regulatory requirements including classification, validation, and post-market surveillance with specific focus on tool combination regulatory pathways.
| # | Description | Level | Role |
|---|---|---|---|
| 8.7.1 | Verify that tool-enabled healthcare AI agents undergo comprehensive regulatory classification analysis determining whether agent+tools combination requires new FDA submission, predicate device comparison, or combination product pathway evaluation. | 1 | V |
| 8.7.2 | Verify that regulatory documentation includes comprehensive tool usage validation demonstrating safety and effectiveness for all approved tool combinations, clinical use cases, and risk-based tool interaction scenarios. | 1 | V |
| 8.7.3 | Verify that tool-enabled agents undergo clinical evidence generation specific to tool combinations including controlled studies validating tool selection accuracy, clinical outcome improvement, and patient safety across different tool usage patterns. | 1 | V |
| 8.7.4 | Verify that post-market surveillance includes monitoring of agent tool usage patterns, adverse events related to tool selection or usage, real-world performance validation, and novel use case detection requiring regulatory assessment. | 2 | H/V |
| 8.7.5 | Verify that regulatory compliance includes comprehensive labeling requirements clearly communicating agent tool capabilities, limitations, approved use cases, contraindications for specific tool combinations, and healthcare professional training requirements. | 2 | V |
| 8.7.6 | Verify that quality system integration includes manufacturing controls for tool-enabled agents covering software configuration management, tool compatibility validation, and change control procedures for both agent and tool components. | 2 | D/V |
| 8.7.7 | Verify that breakthrough device pathway consideration includes evaluation of novel tool-enabled agent capabilities that provide significant advantages over existing healthcare technologies for serious or life-threatening conditions. | 3 | V |
| 8.7.8 | Verify that advanced compliance includes automated regulatory reporting systems tracking agent tool usage, generating required FDA post-market surveillance reports, adverse event documentation, and novel use case identification for regulatory consultation. | 3 | V |
Control Category C8 addresses the fundamental capability that differentiates AI agents from traditional AI/ML medical devices: the ability to autonomously select, access, and use multiple healthcare tools and systems while maintaining clinical safety, regulatory compliance, and security throughout the healthcare environment.